"Taking into consideration that in most cases horses are not specifically reared as food producing animals and usually end up in the food chain at the end of their productive lives, special attention needs to be given to the requirements of Council Directives 96/23/EC and 96/22/EC which should guarantee that the horses slaughtered are safe for human consumption. Notwithstanding third countries' existing obligations to implement a residue monitoring plan and submit this on an annual basis to the Commission services for approval, third countries are expected to implement the following measures for those equidae, meat from which is intended to be exported to the EU:
- Equine animals intended for food production should be identified and a system of identity verification should be established.
- In third countries where anabolic steroids are marketed for fattening purposes, there should either be a prohibition on the administration of anabolic steroids for growth promotion purposes to all equidae or there should be a separate system for equidae which may be slaughtered for export of equine meat to the EU. This would require that equidae intended for meat production for the EU would be identified and segregated from those equidae treated with anabolic steroids.
- Treatment records. The purpose of recording treatments of animals with veterinary medicinal products is to ensure that animals are not slaughtered within the withdrawal period of the medicine in question, thus providing guarantees that the EU Maximum Residue Limit (MRL) for the particular pharmacologically active substance is respected. In the EU stock farmers are required to keep medicines records. On that basis it is expected that treatments with veterinary medicinal products should be recorded on a document linked to and accompanying the identified animal when moving from one premise to another or to the slaughterhouse (food chain information).
- At the time of moving the animal to the slaughterhouse, the competent authority of the third country should be able to guarantee that the required withdrawal periods for veterinary medicinal products administered to the animal and recorded in the food chain information have been respected.
- The third-country exporting equine meat should set up a risk based programme for controls on the use of veterinary medicinal products and substances prohibited for use in the EU. The control programme should include regular inspections on holdings, collection centres and at slaughterhouses."
"Any horse in the EU treated with phenylbutazone must be excluded from the food chain and be signed out of the food chain in the equine passport."
"For equidae caught in the wild, the provisions as laid down for wild land mammals apply. These provisions foresee the submission of an annual residue monitoring plan which is restricted to the analysis of environmental contaminants (e.g. heavy metals). Countries so approved will be listed in the Annex to Commission Decision 2004/432/EC under the column entitled "Equine"."